pmvpharma.comHealthcareFounded: 2013Funding to Date: $170.8MM
PMV is a biotechnology company dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
For more details on financing and valuation for PMV Pharma, register or login.
View Enterprise Value for PMV Pharma.
To read this article and more news on PMV Pharma, register or login.